The timing of hormone replacement therapy may make a big difference in a woman’s risk of developing Alzheimer’s disease. Starting treatment within five years of menopause may lower the risk by as much as 32%, but delaying it until 65 or later can increase the risk by 38%, according to new research presented at the 150th Annual Meeting of the American Neurological Association (ANA).
This article was originally published on MedicalXpress.com